185 related articles for article (PubMed ID: 3722955)
1. [The changes in nuclear DNA amounts in the development and progression of uterine cervical cancer determined by cytofluorometry].
Harada K
Nihon Sanka Fujinka Gakkai Zasshi; 1986 May; 38(5):759-68. PubMed ID: 3722955
[TBL] [Abstract][Full Text] [Related]
2. [Nuclear DNA content and chromosomal counts of cultured cells derived from human cervix with normal and abnormal epithelia].
Hayakawa O; Kusanagi T; Kudo R
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Feb; 37(2):229-36. PubMed ID: 3973446
[TBL] [Abstract][Full Text] [Related]
3. [DNA content in dysplasias and early invasive forms of cervical cancer].
Chebanu FA; Kushch AA; Zelenin AV
Vopr Onkol; 1977; 23(12):64-6. PubMed ID: 602080
[TBL] [Abstract][Full Text] [Related]
4. Proliferative activity in dysplasia, carcinoma in situ and microinvasive carcinoma of the uterine cervix.
Tanaka T
Pathol Res Pract; 1986 Oct; 181(5):531-9. PubMed ID: 3786246
[TBL] [Abstract][Full Text] [Related]
5. [Human papilloma virus (HPV) antigens and DNA in dysplasia and carcinoma of the uterine cervix].
Yamagata S; Tsuchida S; Yamamoto K; Kawamura N; Nakamura T; Ueki S; Sugawa T
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1334-40. PubMed ID: 2555425
[TBL] [Abstract][Full Text] [Related]
6. [Flow cytometric evaluation of DNA ploidy pattern and cell heterogeneity in cervical dysplasia and carcinoma in situ].
Watanabe T
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Dec; 45(12):1381-8. PubMed ID: 8270821
[TBL] [Abstract][Full Text] [Related]
7. [Nuclear DNA content in nasopharyngeal carcinoma (NPC) cells].
Shen ZY; Li MJ; Li QS
Zhonghua Zhong Liu Za Zhi; 1986 Nov; 8(6):435-7. PubMed ID: 3582111
[TBL] [Abstract][Full Text] [Related]
8. Early progression stage of malignancy of uterine cervical dysplasia as revealed by immunohistochemical demonstration of increased DNA-instability.
Khaled A; Imamura Y; Noriki S; Fukuda M
Eur J Histochem; 2000; 44(2):143-56. PubMed ID: 10968362
[TBL] [Abstract][Full Text] [Related]
9. Nuclear DNA study of vulvar intraepithelial and invasive squamous neoplasms.
Fu YS; Reagan JW; Townsend DE; Kaufman RH; Richart RM; Wentz WB
Obstet Gynecol; 1981 May; 57(5):643-52. PubMed ID: 7219914
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric classification of biopsy specimens from cervical intraepithelial neoplasia.
Jakobsen A; Kristensen PB; Poulsen HK
Cytometry; 1983 Sep; 4(2):166-9. PubMed ID: 6628138
[TBL] [Abstract][Full Text] [Related]
11. False-positive squamous cell carcinoma in cervical smears: cytologic-histologic correlation in 19 cases.
Levine PH; Elgert PA; Mittal K
Diagn Cytopathol; 2003 Jan; 28(1):23-7. PubMed ID: 12508178
[TBL] [Abstract][Full Text] [Related]
12. A new marker of maturation in the cervix: the estrogen-regulated 24K protein.
Dressler LG; Ramzy I; Sledge GW; McGuire WL
Obstet Gynecol; 1986 Dec; 68(6):825-31. PubMed ID: 3537878
[TBL] [Abstract][Full Text] [Related]
13. [Correlations between the HPV type, DNA index and evolution of cervical intraepithelial neoplasia (CIN)].
Sassi I; Mangili F; Luchini S; Colombo G; Pezzotta MG; Candiani M; Frigerio A; Santambrogio G; Cantaboni A; Vignali M
Pathologica; 1993; 85(1095):79-84. PubMed ID: 8390639
[TBL] [Abstract][Full Text] [Related]
14. Experience with the Oxford tumour marker in uterine cervical lesions.
Beltrami CA; Di Loreto C; De Nictolis M; Stramazzotti D
Appl Pathol; 1984; 2(1):39-42. PubMed ID: 6395880
[TBL] [Abstract][Full Text] [Related]
15. Relationship between nuclear DNA distribution and estrogen receptors in human mammary carcinomas.
Auer GU; Caspersson TO; Gustafsson SA; Humla SA; Ljung BM; Nordenskjöld BA; Silfverswärd C; Wallgren AS
Anal Quant Cytol; 1980 Dec; 2(4):280-4. PubMed ID: 7469203
[TBL] [Abstract][Full Text] [Related]
16. Nuclear DNA content and the number of Barr bodies in premalignant and malignant lesions of the uterine cervix.
Nishiya I; Ishizaki Y; Sasaki M
Acta Cytol; 1981; 25(4):407-11. PubMed ID: 6945007
[TBL] [Abstract][Full Text] [Related]
17. [The study of DNA ploidy as a prognostic factor in uterine cervical cancer].
Watanabe Y; Ikeda M
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Sep; 44(9):1127-34. PubMed ID: 1453042
[TBL] [Abstract][Full Text] [Related]
18. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
19. Cytospectrophotometric analysis of DNA content in the invasive cancer of the vervix.
Maruszczak AJ; Olkowski ZL; Maruszczak D; McLaren JR
Strahlentherapie; 1975 Mar; 149(3):310-7. PubMed ID: 1145664
[TBL] [Abstract][Full Text] [Related]
20. [Molecular biologic study on the carcinogenesis of HPV in uterine cervical cancer and related lesions--analysis of HPV types 16, 18 E6/E7 gene mRNA].
Nagai N
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Aug; 42(8):823-33. PubMed ID: 2172419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
